Selamectin, a novel avermectin compound, was evaluated for its efficacy against naturally occurring infestations of Psoroptes cuniculi and Sarcoptes scabiei.
A total of 42 New Zealand rabbits with psoroptic mange and 37 Angora rabbits with sarcoptic mange were used in the present study.
On day 0, infested rabbits were treated topically with either selamectin at minimum dose of 6 mg kg1 (6–18 mg kg1 for New Zealand rabbits, n = 31 and 10–12 mg kg1 for Angora rabbits, n = 23) or vehicle only (control groups, n = 11 for New Zealand rabbits, n = 14 for Angora rabbits).
The efficacy of selamectin was assessed both clinically and parasitologically by the presence or absence of viable mites. Rabbits were scraped for sarcoptic mites on days 7, 14, 28, 42 and 56 and had otoscopeic and/or microscopic examination for the detection of Psoroptes mites on days 7, 14, 42 and 56.
Fisher`s exact test was used to assess differences between the vehicle and selamectin treatment in the number of rabbits without mites (cure rates) on each assessment date.
It was found that significantly fewer selamectin-treated rabbits had mites detected on skin scrapings (for S. scabiei) or otoscopeic and/or microscopic examination (for P. cuniculi) (P < 0.01) than the vehicle group.
Results of the present study suggest that selamectin is effective against naturally infestations of P. cuniculi and S. scabiei in rabbits.
Source: Arif Kurtdede, Zafer Karaer, Abuzer Acar, Murat Guzel, C. Cagri Cingi, Kerem Ural, Anil Ica (2007): Use of selamectin for the treatment of psoroptic and sarcoptic mite infestation in rabbits. In: Veterinary Dermatology 18 (1), 18–22.
|
